---
title: RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary
  acute myeloid leukemia
date: '2025-01-17'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39820365/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20250118170341&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: Myeloid malignancies are heterogenous disorders characterized by distinct
  molecular drivers but share convergence of oncogenic signaling pathways and propagation
  by ripe pro-inflammatory niches. Here, we establish a comprehensive transcriptional
  atlas across the spectrum of myeloproliferative neoplasms (MPN) and secondary acute
  myeloid leukemia (sAML) through RNA-sequencing of 158 primary samples encompassing
  CD34+ hematopoietic stem/progenitor cells and CD14+ monocytes. Supported by ...
disable_comments: true
---
Myeloid malignancies are heterogenous disorders characterized by distinct molecular drivers but share convergence of oncogenic signaling pathways and propagation by ripe pro-inflammatory niches. Here, we establish a comprehensive transcriptional atlas across the spectrum of myeloproliferative neoplasms (MPN) and secondary acute myeloid leukemia (sAML) through RNA-sequencing of 158 primary samples encompassing CD34+ hematopoietic stem/progenitor cells and CD14+ monocytes. Supported by ...